Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises. The company is acquiring developmental-stage Ilypsa, a biotech company based in San Francisco that focuses on kidney disease…
Douglas A. McIntyre This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted…
Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups. For…
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares…
AMGN reitr Neutral at Baird.CAT reiterated Neutral at Baird.CFC cut to Mkt Perform at FBR.CSE cut to Mkt Perform at FBR.HOLX raised to Buy at B of A.NILE cut to Sell at…
Barron’s did something very interesting this weekend: they covered companies that could be paying out much higher dividends. This is something investors should applaud as too many companies are determining that shareholders…
AMGN cut to Neutral at Baird.AOG cut to Hold at Jefferies.BEAS cut to Neutral at Credit Suisse.BHE started as Neutral at Credit Suisse.CLS started as Underperform at Credit Suisse.COGO started as Overweight…
(AAPL) Apple’s talks about the Beatles are reportedly close to being settled.(ALL) Allstate is going to stop selling homeowners insurance policies in California.(ALU) Alcatel-Lucent earnings came out, forecasts 10% revenue gains; shares…
